Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Bliss GVS Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1985 on BSE, Jul 2010 on NSE
Last close ₹680.90up ₹32.40 (5.00%)BSE ₹682.50
Share price at the NSE close on 29 Oct 2026. Previous close ₹648.50.
29 Oct: open ₹667.95, high ₹680.90, low ₹652.75
52-week range of traded prices to 29 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,240 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.92
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.22%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,47,694
Bliss GVS Pharma shareholding disclosures
71 filed, newest first. Page 1 of 2.
Oct 2026
15 Oct · Disclosure
Sep 2026
Jul 2026
Jun 2026
May 2026
Jul 2025
28 Jul · Disclosure
Jun 2025
30 Jun · Disclosure
May 2025
Sep 2024
12 Sep · Disclosure
Aug 2024
14 Aug · Disclosure
Jul 2024
9 Jul · Disclosure
Jun 2024
10 Jun · Disclosure
May 2024
15 May · Disclosure
2 May · Disclosure
Jan 2024
12 Jan · Disclosure
Oct 2023
9 Oct · Disclosure
Aug 2023
29 Aug · Disclosure
Jul 2023
26 Jul · Disclosure
Jun 2023
23 Jun · Disclosure
2 Jun · Disclosure
May 2023
12 May · Disclosure
Nov 2022
23 Nov · Disclosure
Sep 2022
15 Sep · Disclosure
Jun 2022
May 2022
Apr 2022
1 Apr · Disclosure
Mar 2022
24 Mar · Disclosure
Nov 2021
18 Nov · Disclosure
Sep 2021
6 Sep · Disclosure
Apr 2021
6 Apr · Disclosure
Mar 2020
7 Mar · Disclosure
Apr 2019
Nov 2017
Oct 2017